Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation

por Eikelenboom, M. J., Uitdehaag, B. M. J., Petzold, A.
Publicado 2011

Retinal inter-eye difference and atrophy progression in multiple sclerosis diagnostics

por Nij Bijvank, Jenny, Uitdehaag, B M J, Petzold, Axel
Publicado 2022

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia

por Nij Bijvank, J.A., van Rijn, L.J., Balk, L.J., Tan, H.S., Uitdehaag, B.M.J., Petzold, A.
Publicado 2019

Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study

por Oort, Q., Dirven, L., Meijer, W., Sikkes, S. A. M., Uitdehaag, B. M. J., Reijneveld, J. C., Taphoorn, M. J. B.
Publicado 2017

A standardized protocol for quantification of saccadic eye movements: DEMoNS

por Nij Bijvank, J. A., Petzold, A., Balk, L. J., Tan, H. S., Uitdehaag, B. M. J., Theodorou, M., van Rijn, L. J.
Publicado 2018

Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis

por Coric, D., Ometto, G., Montesano, G., Keane, P. A., Balk, L. J., Uitdehaag, B. M. J., Petzold, A., Crabb, D. P., Denniston, A. K.
Publicado 2019

Predicting clinical progression in multiple sclerosis after 6 and 12 years

por Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., Schoonheim, M. M.
Publicado 2019

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

por van den Elskamp, I. J., Boden, B., Dattola, V., Knol, D. L., Filippi, M., Kappos, L., Fazekas, F., Wagner, K., Pohl, C., Sandbrink, R., Polman, C. H., Uitdehaag, B. M. J., Barkhof, F.
Publicado 2010

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis

por Holla, F. K., Postma, T. J., Blankenstein, M. A., van Mierlo, T. J. M., Vos, M. J., Sizoo, E. M., de Groot, M., Uitdehaag, B. M. J., Buter, J., Klein, M., Reijneveld, J. C., Heimans, J. J.
Publicado 2016

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanne...

por Weeda, M.M., Middelkoop, S.M., Steenwijk, M.D., Daams, M., Amiri, H., Brouwer, I., Killestein, J., Uitdehaag, B.M.J., Dekker, I., Lukas, C., Bellenberg, B., Barkhof, F., Pouwels, P.J.W., Vrenken, H.
Publicado 2019

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a...

por Vrenken, H., Battaglini, M., de Vos, M. L., Nagtegaal, G. J., Teixeira, B. C. A., Seitzinger, A., Jack, D., Sormani, M. P., Uitdehaag, B. M. J., Versteeg, A., Comi, G., Kappos, L., De Stefano, N., Barkhof, F.
Publicado 2023

Impaired saccadic eye movements in multiple sclerosis are related to altered functional connectivity of the oculomotor brain network

por Nij Bijvank, J.A., Strijbis, E.M.M., Nauta, I.M., Kulik, S.D., Balk, L.J., Stam, C.J., Hillebrand, A., Geurts, J.J.G., Uitdehaag, B.M.J., van Rijn, L.J., Petzold, A., Schoonheim, M.M.
Publicado 2021

A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome

por Korteweg, T., Tintore, M., Uitdehaag, B. M. J., Knol, D. L., Vrenken, H., Rovira, A., Frederiksen, J., Miller, D. H., Fernando, K., Filippi, M., Agosta, F., Rocca, M. A., Fazekas, F., Enzinger, C., Parry, A., Polman, C. H., Montalban, X., Barkhof, F.
Publicado 2009